Overexpression of PD-1 leads to T cell dysfunction in hematological malignancies, such as non-Hodgkin’s tumors, acute myeloid leukemia (AML), and chronic lymphocytic leukemia (34–36). This evidence concerns the gene PDCD1 and B-cell chronic lymphocytic leukemia.